Therapeutic apheresis in kidney diseases: an updated review [PDF]
Renal Failure, 2022 Besides conventional medical therapies, therapeutic apheresis has become an important adjunctive or alternative therapeutic option to immunosuppressive agents for primary or secondary kidney diseases and kidney transplantation.
Yi-Yuan Chen +4 more
doaj +4 more sources
Acoustofluidic-based therapeutic apheresis system [PDF]
Nature CommunicationsTherapeutic apheresis aims to selectively remove pathogenic substances, such as antibodies that trigger various symptoms and diseases. Unfortunately, current apheresis devices cannot handle small blood volumes in infants or small animals, hindering the ...
Mengxi Wu +14 more
doaj +2 more sources
Safety of Therapeutic Apheresis in Children and Adolescents [PDF]
Frontiers in Pediatrics, 2022 BackgroundTherapeutic apheresis (TA) is based on the principles of either removing dissolved pathogenic substances (e.g., antibodies) from the blood plasma or replacing plasma factors. It expands the therapeutic scope for a variety of diseases.
Christina Taylan +9 more
doaj +2 more sources
Polyzwitterionic Coating of Porous Adsorbents for Therapeutic Apheresis [PDF]
Journal of Functional Biomaterials, 2022 Adsorbents for whole blood apheresis need to be highly blood compatible to minimize the activation of blood cells on the biomaterial surface. Here, we developed blood-compatible matrices by surface modification with polyzwitterionic polysulfobetainic and
Vladislav Semak +3 more
doaj +2 more sources
Three decades of experience with therapeutic apheresis at a tertiary academic center: review of indications, clinical practice, special age groups and complications [PDF]
BMC NephrologyIntroduction We performed a comprehensive retrospective analysis of 30-year therapeutic apheresis (TA) activity and practices at one a national apheresis center in Slovenia to describe trends and main TA characteristics.
Alexander Jerman +11 more
doaj +2 more sources
Clinical Remission After Therapeutic Apheresis in a Patient Suffering from Long Term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case Report [PDF]
International Medical Case Reports JournalHarald Burgard Center for Toxopherese®, Private Practice, Wadgassen, GermanyCorrespondence: Harald Burgard, Center for Toxopherese ®, Private Practice, Provinzialstr.
Burgard H
doaj +2 more sources
Successful Pregnancy After Therapeutic Apheresis in a Complex Case of PCOS, Hashimoto Thyroiditis, Recurrent Implantation Failure, and Potential Occupational Environmental Exposure [PDF]
International Medical Case Reports JournalPhilipp Och,1 Stefan R Bornstein,1– 3 Charlotte Steenblock1 1Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 2School of Cardiovascular and Metabolic Medicine and Sciences ...
Och P, Bornstein SR, Steenblock C
doaj +2 more sources
Beyond solute removal: is extracorporeal circuit exposure itself therapeutic in apheresis? [PDF]
Frontiers in MedicineTherapeutic apheresis is conventionally understood through what it removes: pathogenic antibodies, immune complexes, cytokines, or lipoproteins. This framework treats the extracorporeal circuit as a biologically inert delivery mechanism.
Caitlin Raymond
doaj +2 more sources
Campylobacter Colitis as a Trigger for Atypical Hemolytic Uremic Syndrome: About One Case
Case Reports in Nephrology and Dialysis, 2023 We present the case of a 17-year-old Caucasian male whose condition featured acute renal failure, anemia, and deep thrombocytopenia after five consecutive days of diarrhea. Campylobacter coli was identified in stool cultures and, although the direct role
Thomas Quinaux +4 more
doaj +1 more source
Therapeutic Apheresis in Glomerular Diseases after Kidney Transplantation
Journal of Renal and Hepatic Disorders, 2020 Therapeutic apheresis is an extracorporeal treatment that selectively separates abnormal cells or substances from the blood that are linked with or cause certain disease states.
Maurizio Salvadori, Aris Tsalouchos
doaj +1 more source